These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
375 related articles for article (PubMed ID: 27436311)
1. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles. Falsini S; Ristori S Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311 [TBL] [Abstract][Full Text] [Related]
2. The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes. de la Torre LG; Rosada RS; Trombone AP; Frantz FG; Coelho-Castelo AA; Silva CL; Santana MH Colloids Surf B Biointerfaces; 2009 Oct; 73(2):175-84. PubMed ID: 19540734 [TBL] [Abstract][Full Text] [Related]
3. How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy. Muñoz-Úbeda M; Misra SK; Barrán-Berdón AL; Datta S; Aicart-Ramos C; Castro-Hartmann P; Kondaiah P; Junquera E; Bhattacharya S; Aicart E Biomacromolecules; 2012 Dec; 13(12):3926-37. PubMed ID: 23130552 [TBL] [Abstract][Full Text] [Related]
4. Factors affecting DNA binding and stability of association to cationic liposomes. Even-Chen S; Cohen R; Barenholz Y Chem Phys Lipids; 2012 May; 165(4):414-23. PubMed ID: 22715503 [TBL] [Abstract][Full Text] [Related]
5. Influence of plasmid DNA topology on the transfection properties of DOTAP/DOPE lipoplexes. Remaut K; Sanders NN; Fayazpour F; Demeester J; De Smedt SC J Control Release; 2006 Oct; 115(3):335-43. PubMed ID: 17010468 [TBL] [Abstract][Full Text] [Related]
6. Transfection of plasmid DNA by nanocarriers containing a gemini cationic lipid with an aromatic spacer or its monomeric counterpart. Martínez-Negro M; Barrán-Berdón AL; Aicart-Ramos C; Moyá ML; de Ilarduya CT; Aicart E; Junquera E Colloids Surf B Biointerfaces; 2018 Jan; 161():519-527. PubMed ID: 29128838 [TBL] [Abstract][Full Text] [Related]
7. Effect of "helper lipid" on lipoplex electrostatics. Hirsch-Lerner D; Zhang M; Eliyahu H; Ferrari ME; Wheeler CJ; Barenholz Y Biochim Biophys Acta; 2005 Aug; 1714(2):71-84. PubMed ID: 16051183 [TBL] [Abstract][Full Text] [Related]
8. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA. Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006 [TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol enhances lipoplex-cell association and lipofection. Ross PC; Hui SW Biochim Biophys Acta; 1999 Oct; 1421(2):273-83. PubMed ID: 10518697 [TBL] [Abstract][Full Text] [Related]
11. Physicochemical properties of cationic nanoemulsions and liposomes obtained by microfluidization complexed with a single plasmid or along with an oligonucleotide: Implications for CRISPR/Cas technology. Schuh RS; Poletto É; Fachel FNS; Matte U; Baldo G; Teixeira HF J Colloid Interface Sci; 2018 Nov; 530():243-255. PubMed ID: 29982016 [TBL] [Abstract][Full Text] [Related]
12. Ca(2+)-mediated anionic lipid-plasmid DNA lipoplexes. Electrochemical, structural, and biochemical studies. Barrán-Berdón AL; Yélamos B; Malfois M; Aicart E; Junquera E Langmuir; 2014 Oct; 30(39):11704-13. PubMed ID: 25211646 [TBL] [Abstract][Full Text] [Related]
13. Correlation of the physicochemical and structural properties of pDNA/cationic liposome complexes with their in vitro transfection. Balbino TA; Gasperini AA; Oliveira CL; Azzoni AR; Cavalcanti LP; de La Torre LG Langmuir; 2012 Aug; 28(31):11535-45. PubMed ID: 22788539 [TBL] [Abstract][Full Text] [Related]
14. Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9. Hosseini ES; Nikkhah M; Hosseinkhani S Int J Nanomedicine; 2019; 14():4353-4366. PubMed ID: 31354265 [No Abstract] [Full Text] [Related]
15. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy. Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236 [TBL] [Abstract][Full Text] [Related]
16. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532 [TBL] [Abstract][Full Text] [Related]
17. The biological activity of cationic liposomes in drug delivery and toxicity test in animal models. Qi P; Cao M; Song L; Chen C; Liu M; Li N; Wu D; Peng J; Hu G; Zhao J Environ Toxicol Pharmacol; 2016 Oct; 47():159-164. PubMed ID: 27694054 [TBL] [Abstract][Full Text] [Related]
18. DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes. Kim BK; Hwang GB; Seu YB; Choi JS; Jin KS; Doh KO Biochim Biophys Acta; 2015 Oct; 1848(10 Pt A):1996-2001. PubMed ID: 26112463 [TBL] [Abstract][Full Text] [Related]
19. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation. Barichello JM; Ishida T; Kiwada H Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901 [TBL] [Abstract][Full Text] [Related]
20. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]